ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.325,77
0,90%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,06857
-0,22%
Bitcoin
61.748,92
-0,10%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Emmaus Life Sciences Inc (PK) (EMMA)

  7. Emmaus Life Sciences Inc (PK) (EMMA) News

EMMA

Emmaus Life Sciences (PK) (EMMA)

Emmaus Life Sciences Inc (PK)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:EMMA
DatumZeitQuelleÜberschriftSymbolFirma
05/02/202422h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
05/02/202422h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
05/02/202422h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
05/02/202422h37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
05/02/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
05/02/202422h34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
05/02/202422h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
20/12/202316h33Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:EMMAEmmaus Life Sciences Inc (PK)
20/12/202301h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
20/12/202301h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:EMMAEmmaus Life Sciences Inc (PK)
04/10/202322h10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:EMMAEmmaus Life Sciences Inc (PK)
23/08/202315h00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:EMMAEmmaus Life Sciences Inc (PK)
14/08/202321h24Edgar (US Regulatory)Form 8-K - Current reportUSOTC:EMMAEmmaus Life Sciences Inc (PK)
14/08/202320h48Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:EMMAEmmaus Life Sciences Inc (PK)
15/05/202316h06Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EMMAEmmaus Life Sciences Inc (PK)
15/05/202312h34Edgar (US Regulatory)Quarterly Report (10-q)USOTC:EMMAEmmaus Life Sciences Inc (PK)
31/03/202322h33Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EMMAEmmaus Life Sciences Inc (PK)
31/03/202321h23Edgar (US Regulatory)Annual Report (10-k)USOTC:EMMAEmmaus Life Sciences Inc (PK)
07/03/202312h07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EMMAEmmaus Life Sciences Inc (PK)
21/02/202319h23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:EMMAEmmaus Life Sciences Inc (PK)
31/01/202319h14Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:EMMAEmmaus Life Sciences Inc (PK)
19/01/202323h55Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:EMMAEmmaus Life Sciences Inc (PK)
19/01/202322h02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EMMAEmmaus Life Sciences Inc (PK)
17/01/202320h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EMMAEmmaus Life Sciences Inc (PK)
17/01/202320h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EMMAEmmaus Life Sciences Inc (PK)
17/01/202320h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EMMAEmmaus Life Sciences Inc (PK)
12/12/202212h01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EMMAEmmaus Life Sciences Inc (PK)
01/12/202219h53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:EMMAEmmaus Life Sciences Inc (PK)
15/11/202212h05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:EMMAEmmaus Life Sciences Inc (PK)
14/11/202223h22Edgar (US Regulatory)Quarterly Report (10-q)USOTC:EMMAEmmaus Life Sciences Inc (PK)
 Showing the most relevant articles for your search:USOTC:EMMA

Kürzlich von Ihnen besucht

NYSE
MCD
McDonalds
FX
EURJPY
Euro vs Yen
TG
CBK
Commerzbank
USOTC
DTEGY
Deutsche Telekom (QX)
AMEX
XLE
Energy Select Sector SPDR
COIN
SOLUSD
Solana
TG
DTE
Deutsche Telekom
TG
D7G
Nel ASA
NYSE
JPM
JP Morgan Chase
USOTC
ADDYY
Adidas (QX)
USOTC
RHHBY
Roche (QX)
TG
BAYN
Bayer
TG
DBK
Deutsche Bank
TG
BAS
BASF
FX
EURGBP
Euro vs Sterling
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten